Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.
D000284:Administration, Oral; D000700:Analgesics / Q000627:therapeutic use; D000758:Anesthesia; D000773:Anesthesia, Obstetrical; D000818:Animals; D001519:Behavior / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007668:Kidney / Q000187:drug effects; D009292:Narcotic Antagonists / Q000494:pharmacology; D009458:Neuroleptanalgesia; D010146:Pain / Q000188:drug therapy; D010423:Pentazocine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D012119:Respiration / Q000187:drug effects; D019966:Substance-Related Disorders
D000700:Analgesics; D009292:Narcotic Antagonists; D010423:Pentazocine